The altered surface receptor expression and transcriptional programs observed in cancer-associated NK cells are known to perturb the downstream signalling programs mediated by these receptors, such as the proinflammatory DNA-PKCs-Akt-NF-κB, MAPK, AKT and ERK signalling pathways (19). The gene discussed is AKT1; the disease is cancer.